PTCT PTC Therapeutics, Inc. - Common Stock
$72,62
Harga · Agu 19, 2026
Fundamental per Jul 30, 2026
Rentang 52M
$48–$91
57% of range
Peringkat Analis
BUY
21 analysts
Target Harga
$98
+35% upside
P/E (TTM)
9.3
ROE
-331.5%
Margin Laba Bersih
39.4%
Tentang PTC Therapeutics, Inc. - Common Stock Tinjauan perusahaan dari Wikipedia
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
Baca selengkapnya
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
In September 2009, PTC entered into an agreement with Roche for the development of orally bioavailable small molecules for central nervous system diseases. PTC acquired the Bio-e platform in 2019.
Products
In 2017, PTC acquired Emflaza (deflazacort) from Marathon Pharmaceuticals. PTC also owns Translarna, (Ataluren) marketed for nonsense mutation Duchenne muscular dystrophy. Together, the two products generated revenues of 174 million dollars and 260 million dollars in 2017 and 2018 respectively.
PTC has the commercialization rights for WAYLIVRA (volanesorsen) in Latin America.
In 2018, PTC acquired Agilis Biotherapeutics and a gene therapy candidate, GT-AADC, with its compelling clinical data in treating aromatic L-amino acid decarboxylase (AADC) deficiency. AADC deficiency is a rare CNS disorder arising from reductions in the enzyme AADC that result from mutations in the dopa decarboxylase (DDC) gene. As of 2024, the AAV based treatment for AADC deficiency has been approved by the FDA and commercialized in the United States as Kebilidi. It is the first FDA-approved gene therapy treatment for AADC deficiency. This same product was granted EMA approval for use in the European Union under the name Upstaza.
Pipeline
In 2020, PTC acquired Censa Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of CNSA-001 (sepiapterin), a clinical-stage investigational therapy for orphan metabolic diseases, including phenylketonuria (PKU) and other diseases associated with defects in the tetrahydrobiopterin (BH4) biochemical pathways diagnosed at birth.
In 2020, PTC announced the FDA approval of Evrysdi (risdiplam) for the treatment of spinal muscular atrophy (SMA) in adults and children 2 months and older.
In 2024, Novartis has committed $1 billion upfront in a licensing deal with PTC Therapeutics for an experimental treatment for Huntington’s disease, with the potential for an additional $1.9 billion tied to achieving specific development, regulatory, and commercial milestones. PTC Therapeutics’ therapy, known as PTC518, is an oral medication designed to reduce the production of the mutant protein linked to the genetic mutation responsible for the disease. This mutant protein is believed to contribute to neuronal death, driving disease progression. In June, interim data from a Phase 2 trial indicated that PTC518 successfully lowered levels of the mutant protein in both blood and cerebrospinal fluid.
Sumber: Wikipedia (English), CC BY-SA 4.0 · Lihat di Wikipedia ↗
PTCT Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$72.62
Kapitalisasi Pasar
$5.92B
P/E (TTM)
9.3
EPS (TTM)
$7.78
Pendapatan (TTM)
$1.73B
Imbal Hasil Dividen
—
ROE
-331.5%
D/E Utang/Ekuitas
-1.4
Rentang 52M
$48 – $91
PTCT Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
Configure
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan & Laba Bersih
$1.73B
2016-12-31
→
2025-12-31
EPS
$7.78
2019-12-31
→
2025-12-31
Arus Kas Bebas
$702M
2016-12-31
→
2025-12-31
Margin
39.4%
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
Metrik
Tren 5 Tahun
PTCT
Median Rekan
P/E (TTM)
9.3
37.2
P/S (TTM)
3.4
9.9
P/B
-28.8
8.3
EV / EBITDA
4.7
—
Price / FCF (Harga / FCF)
8.4
—
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
Metrik
Tren 5 Tahun
PTCT
Median Rekan
Operating Margin (Margin Operasi)
50.1%
—
Net Profit Margin (Margin Laba Bersih)
39.4%
-15.1%
ROA
29.7%
-23.3%
ROE
-331.5%
-30.6%
ROIC
1044.7%
—
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
Metrik
Tren 5 Tahun
PTCT
Median Rekan
Debt / Equity (Utang / Ekuitas)
-1.4
—
Current Ratio (Rasio Lancar)
2.3
6.3
Quick Ratio (Rasio Cepat)
2.2
—
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Metrik
Tren 5 Tahun
PTCT
Median Rekan
Revenue YoY (Pendapatan YoY)
114.5%
—
Revenue CAGR 3Y (CAGR Pendapatan 3T)
35.3%
—
Revenue CAGR 5Y (CAGR Pendapatan 5T)
35.4%
—
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
Metrik
Tren 5 Tahun
PTCT
Median Rekan
PTCT Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
BELI
21 analis
- Beli Kuat 6 28,6%
- Beli 11 52,4%
- Tahan 3 14,3%
- Jual 1 4,8%
- Jual Kuat 0 0,0%
Target Harga 12 Bulan
14 analis · 2026-08-13
Median
$98.00
Sekarang
$72.62
Rendah
$70.00
Tinggi
$130.00
Target median
$98.00
+34,9%
Target rata-rata
$97.86
+34,8%
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
1.9%
| Periode | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|
| 30 Juni 2026 | $0.92 | $0.43 | 0.49% |
| 31 Maret 2026 | $-0.03 | $-0.48 | 0.45% |
| 31 Des. 2025 | $-1.67 | $0.04 | -1.7% |
| 30 Sep. 2025 | $0.20 | $-1.40 | 1.6% |
| 30 Juni 2025 | $-0.83 | $-1.08 | 0.25% |
| 31 Maret 2025 | $10.04 | $-0.22 | 10.3% |
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| PTCT | $6.19B | 9.8 | 114.5% | 39.4% | -331.5% | — |
| MIRM | $4.10B | -168.1 | 54.7% | -4.5% | -8.2% | — |
| COGT | $5.72B | -16.4 | — | — | -83.1% | — |
| DNTH | $1.78B | -9.8 | -67.3% | -7973.3% | -40.8% | — |
| ERAS | $1.06B | -8.5 | — | — | -35.7% | — |
| CAI | $7.62B | -8.4 | 97.0% | -8.4% | -13.2% | — |
| TVTX | $3.47B | -131.8 | 110.5% | -5.2% | -34.6% | — |
| ACAD | $4.55B | 11.6 | 11.9% | 36.5% | 38.1% | — |
| DYN | $3.23B | -5.6 | — | — | -57.8% | — |
| PBLS | — | — | — | — | — | — |
| CELC | $4.81B | -26.3 | — | — | -244.3% | — |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi 15
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.73B | $807M | $938M | $699M | $539M | $381M | $307M | $265M | $194M | $83M | $37M | $25M | |
| Cost of Revenue | · | · | · | · | · | · | $12M | $13M | $5M | $0 | $0 | · | |
| R&D Expense | $455M | $534M | $667M | $651M | $541M | $478M | $257M | $172M | $117M | $118M | $122M | $80M | |
| SG&A Expense | $347M | $301M | $333M | $326M | $286M | $245M | $203M | $154M | $121M | $97M | $82M | $45M | |
| Operating Expenses | $864M | $1.11B | $1.38B | $1.15B | $913M | $813M | $548M | $380M | $259M | $215M | $204M | $125M | |
| Operating Income | $867M | $-303M | $-440M | $-447M | $-374M | $-432M | $-241M | $-116M | $-64M | $-132M | $-167M | $-99M | |
| Other Non-op | $-18M | $7M | $10M | $-49M | $-58M | $85M | $14M | $129.0K | $-1M | $-1M | $-465.0K | $-213.0K | |
| Pretax Income | $697M | $-363M | $-696M | $-587M | $-518M | $-403M | $-240M | $-128M | $-78M | $-142M | $-170M | $-98M | |
| Income Tax | $14M | $176.0K | $-70M | $-28M | $6M | $35M | $12M | $-29.0K | $1M | $569.0K | $485.0K | $-5M | |
| Net Income | $683M | $-363M | $-627M | $-559M | $-524M | $-438M | $-252M | $-128M | $-79M | $-142M | $-170M | $-94M | |
| EPS (Basic) | $8.58 | $-4.73 | $-8.37 | $-7.79 | $-7.43 | $-6.64 | $-4.27 | $-2.75 | $-2.02 | · | · | $-2.97 | |
| EPS (Diluted) | $7.78 | $-4.73 | $-8.37 | $-7.79 | $-7.43 | $-6.64 | $-4.27 | · | · | · | · | $-2.97 | |
| Shares (Basic) | 79,534,290 | 76,845,055 | 74,838,292 | 71,728,634 | 70,466,393 | 66,027,908 | 58,863,185 | · | · | · | · | 31,565,310 | |
| Shares (Diluted) | 88,311,494 | 76,845,055 | 74,838,292 | 71,728,634 | 70,466,393 | 66,027,908 | 58,863,185 | · | · | · | · | 31,565,310 | |
| EBITDA | $906M | $-227M | $-203M | · | $-310M | $-388M | $-209M | $-90M | $-47M | $-132M | $-167M | $-99M |
Neraca 27
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $985M | $780M | $594M | $280M | $190M | $209M | $288M | $169M | $112M | $58M | $58M | $50M | |
| Short-term Investments | $961M | $360M | $283M | $131M | $584M | $895M | $399M | $58M | $79M | $173M | $281M | $265M | |
| Receivables | $182M | $159M | $161M | $156M | $110M | $70M | $56M | $68M | $40M | $25M | $11M | $4M | |
| Inventory | $80M | $23M | $31M | $22M | $16M | $19M | $19M | $16M | $11M | $0 | · | · | |
| Prepaid Expense | $67M | $44M | $150M | $106M | $55M | $39M | $18M | $9M | $7M | $5M | $6M | $4M | |
| Current Assets | $2.27B | $1.37B | $1.22B | $694M | $954M | $1.23B | $779M | $321M | $249M | $261M | $356M | $324M | |
| PP&E (Net) | $55M | $61M | $87M | $73M | $53M | $34M | $22M | $13M | $8M | $7M | $9M | $9M | |
| PP&E (Gross) | $102M | $94M | $138M | $110M | $80M | $52M | $33M | $20M | $41M | $38M | $37M | $34M | |
| Accum. Depreciation | $47M | $33M | $51M | $37M | $27M | $18M | $12M | $7M | $33M | $31M | $28M | $25M | |
| Goodwill | $82M | $82M | $82M | $82M | $82M | $82M | $82M | $82M | $0 | · | · | · | |
| Intangibles | $389M | $119M | $379M | $706M | $725M | $715M | $710M | $701M | $133M | $0 | · | · | |
| Total Assets | $2.90B | $1.71B | $1.90B | $1.71B | $1.94B | $2.21B | $1.62B | $1.12B | $392M | $269M | $365M | $333M | |
| Accounts Payable | $45M | $17M | $6M | $27M | $23M | $19M | $10M | $6M | $15M | $6M | $6M | $4M | |
| Current Liabilities | $968M | $581M | $603M | $406M | $509M | $277M | $236M | $167M | $82M | $50M | $45M | $32M | |
| Capital Leases | $94M | $75M | $98M | $101M | $74M | $79M | $9M | · | · | · | · | · | |
| Deferred Tax | · | · | $56M | $103M | $137M | $137M | $131M | $122M | $0 | · | · | · | |
| Other Non-current Liabilities | $14M | $21M | $141.0K | $3M | · | $1M | $141.0K | $58.0K | $243.0K | $335.0K | $2M | $2M | |
| Total Liabilities | $3.10B | $2.80B | $2.71B | $2.05B | $1.94B | $1.73B | $1.03B | $768M | $235M | $150M | $139M | $35M | |
| Long-term Debt | · | · | · | · | $431M | · | $314M | $153M | $145M | · | · | · | |
| Total Debt | $287M | $285M | $284M | · | $431M | $309M | $314M | $153M | $145M | $98M | $95M | · | |
| Common Stock | $80.0K | $77.0K | $75.0K | $72.0K | $71.0K | $70.0K | $62.0K | $51.0K | $42.0K | $34.0K | $34.0K | $33.0K | |
| Paid-in Capital | $2.75B | $2.57B | $2.47B | $2.31B | $2.12B | $2.17B | $1.80B | $1.29B | $967M | $856M | $820M | $722M | |
| Retained Earnings | $-2.96B | $-3.65B | $-3.28B | $-2.66B | $-2.10B | $-1.63B | $-1.19B | $-939M | $-814M | $-735M | $-593M | $-423M | |
| AOCI | $11M | $-26M | $-1M | $5M | $-24M | $-61M | $-11M | $1M | $4M | $-1M | $-1M | $-737.0K | |
| Stockholders' Equity | $-205M | $-1.10B | $-819M | $-347M | $1M | $482M | $594M | $351M | $156M | $120M | $226M | $298M | |
| Liabilities + Equity | $2.90B | $1.71B | $1.90B | $1.71B | $1.94B | $2.21B | $1.62B | $1.12B | $392M | $269M | $365M | $333M | |
| Shares Outstanding | 81,474,366 | 77,704,188 | 75,708,889 | 73,104,692 | 70,828,226 | 69,718,096 | 61,935,870 | 50,606,147 | 41,612,395 | 34,169,410 | 33,916,559 | 32,898,392 |
Arus Kas 16
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $39M | $76M | $237M | $129M | $64M | $43M | $32M | $26M | $18M | $3M | $3M | · | |
| Stock-based Comp | $75M | $75M | $102M | $110M | $104M | $70M | $42M | $33M | $31M | $35M | $34M | $19M | |
| Deferred Tax | $-3.0K | $-56M | $-47M | $-34M | $377.0K | $6M | $9M | $0 | $199.0K | $-199.0K | $0 | $0 | |
| Amort. of Intangibles | $25M | $61M | $223M | $117M | $55M | $37M | $28M | $23M | $15M | $0 | $0 | · | |
| Restructuring | · | · | · | · | · | · | · | · | $0 | · | · | · | |
| Other Non-cash | $-85M | $161M | $177M | · | $105M | $124M | $70M | $41M | $20M | · | · | · | |
| Operating Cash Flow | $711M | $-108M | $-158M | $-357M | $-251M | $-194M | $-99M | $-28M | $-10M | $-104M | $-124M | $-57M | |
| CapEx | $9M | $7M | $28M | $32M | $28M | $18M | $14M | $7M | $3M | $2M | $3M | $5M | |
| Investing Cash Flow | $-862M | $44M | $-177M | $290M | $219M | $-562M | $-387M | $-43M | $13M | $104M | $-21M | $-145M | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | $0 | · | $-49.0K | |
| Stock Issued | · | · | · | · | · | $28M | $324M | $118M | $0 | $0 | $0 | $236M | |
| Net Stock Activity | · | · | · | · | · | $28M | $324M | $118M | · | $0 | · | $236M | |
| Financing Cash Flow | $331M | $256M | $646M | $168M | $21M | $669M | $613M | $132M | $44M | $968.0K | $154M | $237M | |
| Net Change in Cash | $203M | $185M | $314M | $99M | $-19M | $-79M | $126M | $58M | $53M | $299.0K | $8M | $34M | |
| Taxes Paid | $37M | $18M | $14M | $5M | $8M | $26M | $2M | $2M | $1M | $943.0K | $111.0K | $0 | |
| Free Cash Flow | $702M | $-114M | $-187M | · | $-280M | $-212M | $-112M | $-35M | $-13M | $-105M | $-127M | $-62M |
Profitabilitas 7
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 50.1% | -37.5% | -46.9% | · | -69.5% | -113.4% | -78.6% | -43.7% | -33.1% | -159.7% | -454.6% | -393.8% | |
| Net Margin | 39.4% | -45.0% | -66.8% | · | -97.3% | -115.1% | -82.0% | -48.4% | -40.6% | -171.8% | -463.6% | -371.4% | |
| Pretax Margin | 40.2% | -45.0% | -74.2% | · | -96.2% | -105.8% | -78.2% | -48.4% | -40.0% | -171.1% | -462.3% | -390.0% | |
| EBITDA Margin | 52.3% | -28.1% | -21.6% | · | -57.6% | -102.0% | -68.1% | -33.8% | -24.0% | -159.7% | -454.6% | -393.8% | |
| ROA | 29.7% | -20.2% | -34.8% | · | -25.3% | -22.9% | -18.3% | -17.0% | -23.9% | -44.8% | -48.6% | -38.6% | |
| ROE | -331.5% | 33.8% | 84.1% | · | -985.1% | -88.3% | -40.0% | -34.8% | -57.2% | -82.2% | -65.0% | -43.1% | |
| ROIC | 1044.7% | 37.2% | 74.0% | · | -87.4% | -59.4% | -27.8% | -23.0% | -21.7% | -60.9% | -52.3% | -31.7% |
Likuiditas & Solvabilitas 4
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.3 | 2.4 | 2.0 | · | 1.9 | 4.4 | 3.3 | 1.9 | 3.0 | 5.3 | 7.8 | 10.0 | |
| Quick Ratio | 2.2 | 2.2 | 1.7 | · | 1.7 | 4.2 | 3.1 | 1.8 | 2.8 | 5.2 | 7.7 | 9.8 | |
| Debt / Equity | -1.4 | -0.3 | -0.3 | · | 300.0 | 0.6 | 0.5 | 0.4 | 0.9 | 0.8 | 0.4 | · | |
| LT Debt / Equity | · | -0.3 | -0.3 | · | 196.0 | 0.6 | 0.5 | 0.4 | 0.9 | 0.8 | 0.4 | · |
Efisiensi 3
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.4 | 0.5 | · | 0.3 | 0.2 | 0.2 | 0.4 | 0.6 | 0.3 | 0.1 | 0.1 | |
| Inventory Turnover | · | · | · | · | · | · | 0.7 | · | 0.9 | · | · | · | |
| Receivables Turnover | 10.2 | 5.1 | 5.9 | · | 6.0 | 6.1 | 5.0 | 4.9 | 6.0 | 4.6 | 4.7 | 9.3 |
Tingkat Pertumbuhan 3
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 114.5% | -14.0% | 34.2% | 29.8% | 41.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 35.3% | 14.4% | 35.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 35.4% | · | · | · | · | · | · | · | · | · | · | · |
Valuasi (TTM) 13
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.73B | $807M | $938M | $699M | $539M | $381M | $307M | $265M | $194M | $83M | $37M | $25M | |
| Net Income TTM | $683M | $-363M | $-627M | $-559M | $-524M | $-438M | $-252M | $-128M | $-79M | $-142M | $-170M | $-94M | |
| Market Cap | $6.19B | $3.51B | $2.09B | · | $2.82B | $4.25B | $2.97B | $1.74B | $694M | $373M | $1.10B | $1.70B | |
| Enterprise Value | $4.53B | $2.65B | $1.49B | · | $2.48B | $3.46B | $2.60B | $1.66B | $648M | $239M | $855M | · | |
| P/E | 9.8 | -9.5 | -3.3 | -4.9 | -5.4 | -9.2 | -11.2 | -10.7 | -5.2 | -3.4 | -10.1 | -17.4 | |
| P/S | 3.6 | 4.3 | 2.2 | · | 5.2 | 11.2 | 9.7 | 6.6 | 3.6 | 4.5 | 29.9 | 67.5 | |
| P/B | -30.1 | -3.2 | -2.5 | · | 1961.8 | 8.8 | 5.0 | 5.0 | 4.4 | 3.1 | 4.9 | 5.7 | |
| P / Cash Flow | 8.7 | -32.6 | -13.2 | · | -11.2 | -21.9 | -30.2 | -62.8 | -69.0 | -3.6 | -8.8 | -29.7 | |
| P / FCF | 8.8 | -30.7 | -11.2 | · | -10.1 | -20.1 | -26.5 | -50.0 | -52.7 | -3.5 | -8.6 | -27.5 | |
| EV / EBITDA | 5.0 | -11.7 | -7.4 | · | -8.0 | -8.9 | -12.5 | -18.6 | -13.9 | -1.8 | -5.1 | · | |
| EV / FCF | 6.5 | -23.2 | -8.0 | · | -8.9 | -16.3 | -23.2 | -47.9 | -49.2 | -2.3 | -6.7 | · | |
| EV / Revenue | 2.6 | 3.3 | 1.6 | · | 4.6 | 9.1 | 8.5 | 6.3 | 3.3 | 2.9 | 23.2 | · | |
| Earnings Yield | 10.2% | -10.5% | -30.4% | -20.4% | -18.6% | -10.9% | -8.9% | -9.3% | -19.2% | -29.4% | -9.9% | -5.7% |
Laporan Laba Rugi 14
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $361M | $273M | $165M | $211M | $179M | $1.18B | $213M | $197M | $187M | $210M | $307M | $197M | $214M | $220M | $167M | $217M | |
| R&D Expense | $99M | $101M | $133M | $100M | $113M | $109M | $125M | $161M | $132M | $116M | $121M | $164M | $186M | $195M | $189M | $165M | |
| SG&A Expense | $81M | $86M | $97M | $84M | $85M | $81M | $85M | $73M | $70M | $73M | $76M | $81M | $88M | $87M | $93M | $80M | |
| Operating Expenses | $212M | $228M | $236M | $208M | $214M | $206M | $376M | $251M | $227M | $256M | $301M | $315M | $423M | $338M | $368M | $285M | |
| Operating Income | $149M | $45M | $-71M | $3M | $-35M | $970M | $-162M | $-55M | $-40M | $-45M | $6M | $-118M | $-210M | $-118M | $-200M | $-68M | |
| Other Non-op | $-3M | $2M | $-13M | $7M | $-6M | $-6M | $9M | $-2M | $-2M | $2M | $19M | $-20M | $1M | $10M | $35M | $-38M | |
| Pretax Income | $98M | $-2M | $-139M | $-23M | $-71M | $930M | $-95M | $-98M | $-86M | $-85M | $-157M | $-167M | $-237M | $-135M | $-190M | $-127M | |
| Income Tax | $14M | $347.0K | $-4M | $-39M | $-6M | $63M | $-29M | $9M | $13M | $7M | $-1M | $-34M | $-39M | $4M | $-19M | $-18M | |
| Net Income | $83M | $-3M | $-135M | $16M | $-65M | $867M | $-66M | $-107M | $-99M | $-92M | $-156M | $-133M | $-199M | $-139M | $-171M | $-109M | |
| EPS (Basic) | $1.01 | $-0.03 | $-1.88 | $0.20 | $-0.83 | $11.09 | $-0.85 | $-1.39 | $-1.29 | $-1.20 | $-2.07 | $-1.76 | $-2.66 | $-1.88 | $-2.35 | $-1.53 | |
| EPS (Diluted) | $0.92 | $-0.03 | $-1.63 | $0.20 | $-0.83 | $10.04 | $-0.85 | $-1.39 | $-1.29 | $-1.20 | $-2.07 | $-1.76 | $-2.66 | $-1.88 | $-2.35 | $-1.53 | |
| Shares (Basic) | 83,006,808 | 82,521,023 | -155,203,905 | 78,471,119 | 78,151,240 | 78,115,836 | -153,301,665 | 76,925,523 | 76,725,070 | 76,496,127 | -148,999,422 | 75,377,997 | 74,730,433 | 73,729,284 | -142,514,082 | 71,654,671 | |
| Shares (Diluted) | 92,020,009 | 82,521,023 | -163,341,037 | 87,115,369 | 78,151,240 | 86,385,922 | -153,301,665 | 76,925,523 | 76,725,070 | 76,496,127 | -148,999,422 | 75,377,997 | 74,730,433 | 73,729,284 | -142,514,082 | 71,654,671 | |
| EBITDA | $149M | $60M | · | $3M | $-35M | $977M | · | $-55M | $-40M | $10M | · | $-118M | $-210M | $-75M | · | $-68M |
Neraca 27
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.05B | $834M | $985M | $673M | $1.02B | $1.48B | $780M | $526M | $655M | $548M | · | $165M | $208M | $167M | · | $104M | |
| Short-term Investments | $1.18B | $1.06B | $961M | $1.02B | $972M | $547M | $360M | $487M | $439M | $336M | · | $130M | $130M | $119M | · | $184M | |
| Receivables | $239M | $220M | $182M | $203M | $196M | $210M | $159M | $200M | $187M | $198M | · | $166M | $178M | $202M | · | $124M | |
| Inventory | $91M | $76M | $80M | $53M | $34M | $22M | $23M | $36M | $32M | $30M | · | $36M | $32M | $27M | · | $15M | |
| Prepaid Expense | $58M | $66M | $67M | $64M | $54M | $57M | $44M | $33M | $46M | $56M | · | $44M | $42M | $99M | · | $90M | |
| Current Assets | $2.62B | $2.25B | $2.27B | $2.01B | $2.27B | $2.32B | $1.37B | $1.28B | $1.36B | $1.17B | · | $540M | $590M | $613M | · | $517M | |
| PP&E (Net) | $51M | $53M | $55M | $57M | $57M | $59M | $61M | $63M | $66M | $93M | · | $85M | $82M | $79M | · | $67M | |
| PP&E (Gross) | · | · | $102M | · | · | · | $94M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $47M | · | · | · | $33M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $82M | $82M | $82M | $82M | $82M | $82M | $82M | $82M | $82M | $82M | · | $82M | $82M | $82M | · | $82M | |
| Intangibles | $403M | $381M | $389M | $396M | $144M | $118M | $119M | $330M | $330M | $330M | · | $423M | $452M | $686M | · | $750M | |
| Total Assets | $3.25B | $2.87B | $2.90B | $2.64B | $2.63B | $2.66B | $1.71B | $1.84B | $1.92B | $1.79B | · | $1.26B | $1.34B | $1.61B | · | $1.58B | |
| Accounts Payable | $40M | $25M | $45M | $37M | $27M | $15M | $17M | $13M | $24M | $27M | · | $19M | $26M | $26M | · | $21M | |
| Current Liabilities | $771M | $924M | $968M | $866M | $628M | $595M | $581M | $611M | $610M | $575M | · | $492M | $476M | $442M | · | $420M | |
| Capital Leases | $88M | $90M | $94M | $95M | $71M | $74M | $75M | $83M | $79M | $105M | · | $100M | $100M | $100M | · | $102M | |
| Deferred Tax | · | · | · | · | · | · | · | $56M | $56M | $56M | · | $52M | $52M | $103M | · | $137M | |
| Other Non-current Liabilities | $15M | $14M | $14M | $3M | $8M | $22M | $21M | $77.0K | $141.0K | $141.0K | · | $141.0K | $141.0K | $141.0K | · | $5M | |
| Total Liabilities | $3.42B | $3.05B | $3.10B | $2.80B | $2.84B | $2.84B | $2.80B | $2.90B | $2.90B | $2.68B | · | $1.93B | $1.92B | $2.07B | · | $1.80B | |
| Long-term Debt | $591M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Debt | $591M | $287M | · | $286M | $286M | $286M | · | $285M | $285M | $285M | · | $573M | $573M | $572M | · | $283M | |
| Common Stock | $82.0K | $81.0K | $80.0K | $79.0K | $78.0K | $78.0K | $77.0K | $76.0K | $76.0K | $76.0K | · | $75.0K | $75.0K | $73.0K | · | $71.0K | |
| Paid-in Capital | $2.71B | $2.78B | $2.75B | $2.67B | $2.63B | $2.61B | $2.57B | $2.53B | $2.51B | $2.49B | · | $2.45B | $2.42B | $2.34B | · | $2.22B | |
| Retained Earnings | $-2.88B | $-2.97B | $-2.96B | $-2.83B | $-2.85B | $-2.78B | $-3.65B | $-3.58B | $-3.47B | $-3.38B | · | $-3.13B | $-2.99B | $-2.80B | · | $-2.49B | |
| AOCI | $6M | $8M | $11M | $6M | $7M | $-14M | $-26M | $-4M | $-16M | $-6M | · | $10M | $-1M | $-2M | · | $36M | |
| Stockholders' Equity | $-165M | $-180M | $-205M | $-156M | $-207M | $-186M | $-1.10B | $-1.05B | $-980M | $-894M | $-819M | $-671M | $-579M | $-458M | $-347M | $-227M | |
| Liabilities + Equity | $3.25B | $2.87B | $2.90B | $2.64B | $2.63B | $2.66B | $1.71B | $1.84B | $1.92B | $1.79B | · | $1.26B | $1.34B | $1.61B | · | $1.58B | |
| Shares Outstanding | 83,327,286 | 82,882,024 | 81,474,366 | 79,931,766 | 79,378,145 | 79,225,276 | 77,704,188 | 76,952,124 | 76,900,123 | 76,653,960 | · | 75,459,022 | 75,318,233 | 74,012,034 | · | 71,854,892 |
Arus Kas 13
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $16M | $15M | $13M | $11M | $8M | $7M | $7M | $6M | $7M | $55M | $81M | $62M | $51M | $43M | $39M | $34M | |
| Stock-based Comp | $23M | $23M | $19M | $19M | $19M | $18M | $17M | $20M | $19M | $18M | $17M | $27M | $29M | $29M | $27M | $29M | |
| Deferred Tax | · | $-10.0K | $1.0K | · | · | $2.0K | $-56M | $-3.0K | $2.0K | $-1.0K | $4M | $-2.0K | $-51M | $-4.0K | · | · | |
| Amort. of Intangibles | $12M | $12M | $9M | $8M | $4M | $4M | $3M | $3M | $3M | $52M | $77M | $59M | $47M | $39M | $36M | $31M | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | · | $23M | $8M | · | · | · | |
| Other Non-cash | · | $-95M | · | · | · | $-22M | · | · | · | $89M | · | · | · | $38M | · | · | |
| Operating Cash Flow | $129M | $-59M | $-34M | $-66M | $-58M | $870M | $-30M | $-77M | $-71M | $71M | $-100M | $-15M | $-14M | $-29M | $-166M | $-38M | |
| CapEx | $2M | $1M | $2M | $3M | $1M | $2M | $4M | $522.0K | $-7M | $10M | $6M | $6M | $6M | $10M | $9M | $5M | |
| Investing Cash Flow | $-123M | $-94M | $34M | $-290M | $-422M | $-184M | $268M | $-43M | $-66M | $-115M | $-94M | $-30M | $-24M | $-29M | $32M | $136M | |
| Financing Cash Flow | $212M | $6M | $303M | $15M | $4M | $9M | $26M | $-18M | $246M | $540.0K | $620M | $3M | $18M | $4M | $303M | $-140M | |
| Net Change in Cash | $216M | $-148M | $312M | $-347M | $-463M | $701M | $256M | $-129M | $104M | $-46M | $429M | $-43M | $-9M | $-62M | $175M | $-54M | |
| Taxes Paid | · | · | $-3M | $936.0K | $36M | $3M | $5M | $7M | $4M | $2M | $524.0K | $4M | $7M | $2M | $893.0K | $1M | |
| Free Cash Flow | · | $-60M | · | · | · | $868M | · | · | · | $61M | · | · | · | $-40M | · | · |
Profitabilitas 7
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 41.3% | 16.5% | · | 1.4% | -19.5% | 82.5% | · | -27.7% | -21.5% | -21.6% | · | -60.1% | -98.0% | -53.4% | · | -31.4% | |
| Net Margin | 23.2% | -1.0% | · | 7.5% | -36.2% | 73.7% | · | -54.2% | -53.1% | -43.6% | · | -67.6% | -93.0% | -63.0% | · | -50.3% | |
| Pretax Margin | 27.1% | -0.90% | · | -10.9% | -39.7% | 79.1% | · | -49.8% | -45.9% | -40.3% | · | -84.8% | -111.1% | -61.3% | · | -58.6% | |
| EBITDA Margin | 41.3% | 22.1% | · | 1.4% | -19.5% | 83.1% | · | -27.7% | -21.5% | 4.7% | · | -60.1% | -98.0% | -33.9% | · | -31.4% | |
| ROA | 2.8% | -0.10% | · | 0.71% | -2.9% | 39.0% | · | -6.9% | -6.1% | -5.4% | · | -9.4% | -12.7% | -8.2% | · | -6.1% | |
| ROE | -44.9% | 1.5% | · | -2.6% | 10.9% | -160.5% | · | 12.4% | 12.7% | 13.6% | · | 29.6% | 52.2% | 50.7% | · | 179.2% | |
| ROIC | 30.0% | 48.2% | · | -1.6% | -40.2% | 904.6% | · | 7.7% | 6.7% | 8.1% | · | 96.6% | 2648.9% | -105.7% | · | -104.9% |
Likuiditas & Solvabilitas 4
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.4 | 2.4 | · | 2.3 | 3.6 | 3.9 | · | 2.1 | 2.2 | 2.0 | · | 1.1 | 1.2 | 1.4 | · | 1.2 | |
| Quick Ratio | 3.2 | 2.3 | · | 2.2 | 3.5 | 3.8 | · | 2.0 | 2.1 | 1.9 | · | 0.9 | 1.1 | 1.1 | · | 1.0 | |
| Debt / Equity | -3.6 | -1.6 | · | -1.8 | -1.4 | -1.5 | · | -0.3 | -0.3 | -0.3 | · | -0.9 | -1.0 | -1.3 | · | -1.2 | |
| LT Debt / Equity | -3.2 | · | · | · | -1.4 | -1.5 | · | -0.3 | -0.3 | -0.3 | · | -0.9 | -1.0 | -1.3 | · | -1.2 |
Efisiensi 2
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.5 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Receivables Turnover | 1.7 | 1.3 | · | 1.0 | 0.9 | 5.8 | · | 1.1 | 1.0 | 1.1 | · | 1.4 | 1.4 | 1.3 | · | 2.0 |
Valuasi (TTM) 13
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.02B | $1.84B | · | $1.76B | $1.74B | $1.77B | · | $790M | $807M | $841M | · | $848M | $817M | $752M | · | $670M | |
| Net Income TTM | $32M | $815M | · | $711M | $596M | $569M | · | $-430M | $-523M | $-562M | · | $-580M | $-599M | $-527M | · | $-522M | |
| Market Cap | $6.80B | $5.65B | · | $4.91B | $3.88B | $4.04B | · | $2.85B | $2.35B | $2.23B | · | $1.69B | $3.06B | $3.59B | · | $3.61B | |
| Enterprise Value | $5.16B | $4.04B | · | $3.50B | $2.17B | $2.30B | · | $2.13B | $1.54B | $1.63B | · | $1.97B | $3.30B | $3.87B | · | $3.60B | |
| P/E | 313.7 | 7.3 | · | 7.7 | 7.5 | 8.3 | · | -6.6 | -4.4 | -3.9 | · | -2.9 | -5.0 | -6.6 | · | -6.8 | |
| P/S | 6.6 | 3.1 | · | 2.8 | 2.2 | 2.3 | · | 3.6 | 2.9 | 2.7 | · | 2.0 | 3.8 | 4.8 | · | 5.4 | |
| P/B | -41.1 | -31.3 | · | -31.5 | -18.8 | -21.7 | · | -2.7 | -2.4 | -2.5 | · | -2.5 | -5.3 | -7.8 | · | -15.9 | |
| P / Cash Flow | · | -95.6 | · | · | · | 4.6 | · | · | · | 31.5 | · | · | · | -121.6 | · | · | |
| P / FCF | · | -93.7 | · | · | · | 4.6 | · | · | · | 36.5 | · | · | · | -90.2 | · | · | |
| EV / EBITDA | 34.6 | 66.9 | · | 1161.8 | -62.2 | 2.3 | · | -39.0 | -38.4 | 163.9 | · | -16.7 | -15.7 | -51.8 | · | -52.8 | |
| EV / FCF | · | -67.1 | · | · | · | 2.6 | · | · | · | 26.6 | · | · | · | -97.4 | · | · | |
| EV / Revenue | 5.0 | 2.2 | · | 2.0 | 1.3 | 1.3 | · | 2.7 | 1.9 | 1.9 | · | 2.3 | 4.0 | 5.1 | · | 5.4 | |
| Earnings Yield | 0.32% | 13.8% | · | 13.1% | 13.4% | 12.1% | · | -15.2% | -22.6% | -25.8% | · | -34.9% | -20.2% | -15.1% | · | -14.6% |
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
Laporan Laba Rugi
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Pendapatan | $1.73B | $807M | $938M | $699M | $539M |
| Margin Operasi % | 50.1% | -37.5% | -46.9% | — | -69.5% |
| Laba Bersih | $683M | $-363M | $-627M | $-559M | $-524M |
| EPS Dilusian | $7.78 | $-4.73 | $-8.37 | $-7.79 | $-7.43 |
Neraca
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Utang / Ekuitas | -1.4 | -0.3 | -0.3 | — | 300.0 |
| Rasio Lancar | 2.3 | 2.4 | 2.0 | — | 1.9 |
| Rasio Cepat | 2.2 | 2.2 | 1.7 | — | 1.7 |
Arus Kas
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Arus Kas Bebas | $702M | $-114M | $-187M | — | $-280M |
Sinyal Perdagangan Sinyal beli/jual terbaru dengan harga masuk dan rasio risiko/imbalan
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
📊
Pilih metrik yang penting bagi Anda — klik ➕ di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Pemilik institusional (13F) 405 pengaju · $5.4B total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 84 (+17 vs Kuartal sebelumnya) | 43 (-7 vs Kuartal sebelumnya) | 133 (-6 vs Kuartal sebelumnya) | 109 (+6 vs Kuartal sebelumnya) | -7.1M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| RTW INVESTMENTS, LP | $631.875.072 | 7.746.415 | 11,70% | Saham |
| JANUS HENDERSON GROUP PLC | $479.178.655 | 7.034.622 | 8,87% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $401.986.014 | 4.928.111 | 7,44% | Saham |
| STATE STREET CORP | $375.136.515 | 4.598.952 | 6,95% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $305.000.589 | 3.739.127 | 5,65% | Saham |
| WELLINGTON MANAGEMENT GROUP LLP | $292.435.873 | 3.585.091 | 5,42% | Saham |
| WESTFIELD CAPITAL MANAGEMENT CO LP | $159.563.645 | 1.956.156 | 2,95% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $155.132.041 | 1.901.417 | 2,87% | Saham |
| Hood River Capital Management LLC | $141.818.662 | 1.738.613 | 2,63% | Saham |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $140.519.660 | 1.722.688 | 2,60% | Saham |
| TANG CAPITAL MANAGEMENT LLC | $122.355.000 | 1.500.000 | 2,27% | Saham |
| Driehaus Capital Management LLC | $117.469.528 | 1.440.107 | 2,18% | Saham |
| Jefferies Financial Group Inc. | $110.693.916 | 1.357.042 | 2,05% | Saham |
| FULLER & THALER ASSET MANAGEMENT, INC. | $94.361.749 | 1.156.819 | 1,75% | Saham |
| Pictet Asset Management Holding SA | $93.629.635 | 1.147.844 | 1,73% | Saham |
| ARMISTICE CAPITAL, LLC | $87.393.690 | 1.071.395 | 1,62% | Saham |
| Blue Sparrow, LLC /DE | $85.705.599 | 1.050.700 | 1,59% | Saham |
| D. E. Shaw & Co., Inc. | $77.478.857 | 949.845 | 1,43% | Saham |
| Palo Alto Investors LP | $74.950.268 | 918.846 | 1,39% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $64.449.436 | 790.112 | 1,19% | Saham |
| RENAISSANCE TECHNOLOGIES LLC | $59.015.895 | 723.500 | 1,09% | Saham |
| Boston Partners | $57.080.953 | 699.871 | 1,06% | Saham |
| FMR LLC | $56.956.987 | 698.259 | 1,05% | Saham |
| BANK OF AMERICA CORP /DE/ | $56.350.840 | 690.828 | 1,04% | Saham |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $53.377.940 | 654.382 | 0,99% | Saham |
| DIMENSIONAL FUND ADVISORS LP | $51.486.821 | 631.199 | 0,95% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $47.953.943 | 587.887 | 0,89% | Saham |
| Ensign Peak Advisors, Inc | $41.442.128 | 508.056 | 0,77% | Saham |
| AMERICAN CENTURY COMPANIES INC | $40.866.277 | 500.995 | 0,76% | Saham |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $36.050.432 | 441.957 | 0,67% | Saham |
| Parkman Healthcare Partners LLC | $35.539.315 | 435.691 | 0,66% | Saham |
| LOOMIS SAYLES & CO L P | $35.387.921 | 433.835 | 0,66% | Saham |
| Defilade Capital Management, L.P. | $35.376.827 | 433.699 | 0,66% | Saham |
| GOLDMAN SACHS GROUP INC | $34.153.522 | 418.702 | 0,63% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $32.274.149 | 395.662 | 0,60% | Saham |
| BNP PARIBAS FINANCIAL MARKETS | $30.892.190 | 378.720 | 0,57% | Saham |
| Qube Research & Technologies Ltd | $25.398.777 | 311.374 | 0,47% | Saham |
| ARMISTICE CAPITAL, LLC | $24.471.000 | 300.000 | 0,45% | Opsi beli |
| Public Sector Pension Investment Board | $23.249.326 | 285.023 | 0,43% | Saham |
| SEGALL BRYANT & HAMILL, LLC | $22.165.424 | 271.735 | 0,41% | Saham |
| CITADEL ADVISORS LLC | $20.338.011 | 249.332 | 0,38% | Saham |
| MORGAN STANLEY | $18.990.210 | 232.808 | 0,35% | Saham |
| Boxer Capital Management, LLC | $16.314.000 | 200.000 | 0,30% | Saham |
| RHUMBLINE ADVISERS | $15.718.994 | 192.706 | 0,29% | Saham |
| AMERIPRISE FINANCIAL INC | $13.904.178 | 170.457 | 0,26% | Saham |
| PRUDENTIAL FINANCIAL INC | $13.746.176 | 168.520 | 0,25% | Saham |
| BlackRock, Inc. | $13.589.562 | 166.600 | 0,25% | Saham |
| Rock Springs Capital Management LP | $13.238.648 | 162.298 | 0,25% | Saham |
| Hudson Bay Capital Management LP | $13.033.091 | 159.778 | 0,24% | Saham |
| Russell Investments Group, Ltd. | $12.687.724 | 155.544 | 0,23% | Saham |
| Schonfeld Strategic Advisors LLC | $12.025.457 | 147.425 | 0,22% | Saham |
| MARSHALL WACE, LLP | $11.724.301 | 143.733 | 0,22% | Saham |
| Swiss National Bank | $11.539.300 | 141.465 | 0,21% | Saham |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $11.063.583 | 135.633 | 0,20% | Saham |
| Legal & General Group Plc | $10.362.979 | 127.044 | 0,19% | Saham |
| CITIGROUP INC | $9.272.143 | 113.671 | 0,17% | Saham |
| FIRST TRUST ADVISORS LP | $9.246.285 | 113.354 | 0,17% | Saham |
| Longaeva Partners L.P. | $9.119.771 | 111.803 | 0,17% | Saham |
| JUPITER ASSET MANAGEMENT LTD | $8.927.184 | 109.442 | 0,17% | Saham |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $8.215.404 | 100.716 | 0,15% | Saham |
| SECTOR GAMMA AS | $8.157.000 | 100.000 | 0,15% | Saham |
| WCM INVESTMENT MANAGEMENT, LLC | $7.651.184 | 93.799 | 0,14% | Saham |
| PANAGORA ASSET MANAGEMENT INC | $7.256.141 | 88.956 | 0,13% | Saham |
| VOYA INVESTMENT MANAGEMENT LLC | $7.239.501 | 88.752 | 0,13% | Saham |
| ALLIANCEBERNSTEIN L.P. | $7.217.488 | 105.937 | 0,13% | Saham |
| Aquatic Capital Management LLC | $6.808.648 | 83.470 | 0,13% | Saham |
| XTX Topco Ltd | $6.682.459 | 81.923 | 0,12% | Saham |
| MOORE CAPITAL MANAGEMENT, LP | $6.165.713 | 75.588 | 0,11% | Saham |
| PINNACLE ASSOCIATES LTD | $5.745.383 | 70.435 | 0,11% | Saham |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $5.744.722 | 84.320 | 0,11% | Saham |
| VANGUARD ASSET MANAGEMENT, Ltd | $5.614.300 | 68.828 | 0,10% | Saham |
| Capricorn Fund Managers Ltd | $5.212.323 | 63.900 | 0,10% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5.000.241 | 61.300 | 0,09% | Opsi beli |
| INTECH INVESTMENT MANAGEMENT LLC | $4.696.882 | 57.581 | 0,09% | Saham |
| ExodusPoint Capital Management, LP | $4.672.166 | 57.278 | 0,09% | Saham |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $4.561.884 | 55.926 | 0,08% | Saham |
| BARCLAYS PLC | $4.169.858 | 51.120 | 0,08% | Saham |
| ORBIMED ADVISORS LLC | $4.005.087 | 49.100 | 0,07% | Saham |
| MetLife Investment Management, LLC | $3.932.653 | 48.212 | 0,07% | Saham |
| Point72 Europe (London) LLP | $3.829.919 | 62.407 | 0,07% | Saham |
| MILLENNIUM MANAGEMENT LLC | $3.792.516 | 46.494 | 0,07% | Saham |
| Phocas Financial Corp. | $3.766.087 | 46.170 | 0,07% | Saham |
| MARTINGALE ASSET MANAGEMENT L P | $3.627.826 | 44.475 | 0,07% | Saham |
| Quadrature Capital Ltd | $3.589.488 | 44.005 | 0,07% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3.531.981 | 43.300 | 0,07% | Opsi jual |
| STATE OF WISCONSIN INVESTMENT BOARD | $3.436.299 | 42.127 | 0,06% | Saham |
| CREDIT AGRICOLE S A | $3.344.370 | 41.000 | 0,06% | Saham |
| Fisher Asset Management, LLC | $3.322.345 | 40.730 | 0,06% | Saham |
| HSBC HOLDINGS PLC | $3.200.425 | 38.732 | 0,06% | Saham |
| NEW YORK STATE COMMON RETIREMENT FUND | $3.134.490 | 38.427 | 0,06% | Saham |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $3.114.179 | 38.178 | 0,06% | Saham |
| CenterBook Partners LP | $3.082.938 | 37.795 | 0,06% | Saham |
| Rafferty Asset Management, LLC | $3.069.805 | 37.634 | 0,06% | Saham |
| FIFTH THIRD BANCORP | $3.044.843 | 37.328 | 0,06% | Saham |
| BURNEY CO/ | $3.044.192 | 37.320 | 0,06% | Saham |
| Vanguard Global Advisers, LLC | $3.033.180 | 37.185 | 0,06% | Saham |
| Arrowpoint Investment Partners (Singapore) Pte. Ltd. | $3.007.731 | 36.873 | 0,06% | Saham |
| Louisiana State Employees Retirement System | $2.969.148 | 36.400 | 0,05% | Saham |
| JANE STREET GROUP, LLC | $2.854.950 | 35.000 | 0,05% | Opsi jual |
| CASTLEARK MANAGEMENT LLC | $2.765.223 | 33.900 | 0,05% | Saham |
Orang dalam perusahaan 33 orang dalam · 13 pejabat · 14 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Stuart Walter Peltz | Chief Executive Officer | 1 Feb. 2022 S | 38.728 | 0 | 0 | $0 |
| Pierre Gravier | CHIEF FINANCIAL OFFICER | 14 Juli 2026 S | 83.986 | 0 | 1 | $-280.743 |
| Emily Luisa Hill | Chief Financial Officer | 1 Feb. 2022 S | 37.169 | 0 | 0 | $0 |
| Shane William Charles Kovacs | Chief Financial Officer | 9 Mei 2017 M | 37.850 | 0 | 0 | $0 |
| Claudia De Oliveira Ribeiro Hirawat | President | 15 Jan. 2015 M | 39.247 | 0 | 0 | $0 |
| Marcio Souza | Chief Operating Officer | 10 Feb. 2020 M | 6.744 | 0 | 0 | $0 |
| Neil Gregory Almstead | CHIEF TECHNICAL OPS OFFICER | 9 Juli 2026 M | 60.299 | 0 | 20 | $-9.184.852 |
| Mark Elliott Boulding | EXEC. VP AND CLO | 6 Juli 2026 M | 105.272 | 0 | 12 | $-1.254.986 |
| Christine Marie Utter | SVP, CHIEF ACCOUNTING OFFICER | 17 Juni 2026 M | 70.199 | 0 | 1 | $-1.487.474 |
| Eric Pauwels | CHIEF BUSINESS OFFICER | 10 Juni 2026 S | 73.411 | 0 | 28 | $-7.477.160 |
| Mark Rothera | Chief Commercial Officer | 24 Mei 2017 M | 33.739 | 0 | 0 | $0 |
| Tuyen Ong | Chief Medical Officer | 3 Jan. 2017 A | 6.000 | 0 | 0 | $0 |
| Robert J. Spiegel | Chief Medical Officer | 4 Jan. 2016 A | 3.239 | 0 | 0 | $0 |
| Hege Elisabeth Sollie-Zetlmayer | Direktur | 28 Juli 2026 A | 52.526 | 0 | 0 | $0 |
| Mary L. Smith | Direktur | 9 Juli 2026 M | 21.813 | 0 | 2 | $-1.425.060 |
| Stephanie Okey | Direktur | 7 Jan. 2022 A | 4.163 | 0 | 0 | $0 |
| Emma Reeve | Direktur | 7 Jan. 2022 A | 7.528 | 0 | 0 | $0 |
| Allan Steven Jacobson | Direktur | 7 Jan. 2022 A | 8.348 | 0 | 0 | $0 |
| Dawn Svoronos | Direktur | 7 Jan. 2022 A | 29.755 | 0 | 0 | $0 |
| Jerome B Zeldis | Direktur | 7 Jan. 2022 A | 6.500 | 0 | 0 | $0 |
| Cameron Geoffrey Mcdonough | Direktur | 3 Jan. 2017 A | — | 0 | 0 | $0 |
| Adam Koppel | Direktur | 3 Jan. 2017 A | 2.333.333 | 0 | 0 | $0 |
| Ronald C Renaud JR | Direktur | 3 Jan. 2017 A | — | 0 | 0 | $0 |
| Richard Aldrich | Direktur | 8 Juni 2015 M | 0 | 0 | 0 | $0 |
| Michael L Kranda | Direktur | 16 Maret 2015 S | 2.242 | 0 | 0 | $0 |
| Axel Bolte | Direktur | 25 Juni 2013 P | 20.000 | 0 | 0 | $0 |
| HBM Healthcare Investments (Cayman) Ltd. | Pemilik 10% | 17 Des. 2013 S | 2.441.504 | 0 | 0 | $0 |
| Matthew B. Klein | — | 4 Agu 2026 S | 383.868 | 0 | 1 | $-705.722 |
| Michael Schmertzler | — | 2 Jan. 2026 A | 163.266 | 0 | 0 | $0 |
| Glenn Steele JR MD PHD | — | 2 Jan. 2026 A | 22.500 | 0 | 1 | $-916.200 |
| David P Southwell | — | 2 Jan. 2026 A | 20.850 | 0 | 0 | $0 |
| Complete Pharma Holdings II, LLC | — | 28 April 2017 J | 0 | 0 | 0 | $0 |
| CREDIT SUISSE/ | — | 25 Juni 2013 C | 2.256.882 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Aktivis & pemilik 5%+ 3 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| Brookside Capital Partners Fund, L.P., Brookside Capital Trading Fund, L.P. ×5 pengajuan | 30 Jan. 2015 | — | Pengajuan awal | — | SEC |
| HBM Healthcare Investments (Cayman) Ltd. (“HBM”) ×2 pengajuan | 12 Nov. 2014 | — | Pengajuan awal | — | SEC |
| HBM Healthcare Investments (Cayman) Ltd. | 5 Juli 2013 | — | Pengajuan awal | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Kepemilikan ETF Dimiliki oleh 88 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| BBP · ETFis Series Trust I | 1,37% | 12.510 NS | 30 April 2026 | N-PORT |
| SIXS · EXCHANGE TRADED CONCEPTS TRUST | 1,30% | 22.380 NS | 31 Mei 2026 | N-PORT |
| GURU · Global X Funds | 1,03% | 9.268 NS | 30 April 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,93% | 73.928 NS | 30 April 2026 | N-PORT |
| VAMO · Cambria ETF Trust | 0,83% | 10.625 NS | 30 April 2026 | N-PORT |
| VMAX · Lattice Strategies Trust | 0,72% | 5.120 NS | 30 April 2026 | N-PORT |
| FNY · First Trust Exchange-Traded AlphaDE… | 0,51% | 40.257 NS | 30 April 2026 | N-PORT |
| MMSC · First Trust Exchange-Traded Fund VI… | 0,49% | 3.490 NS | 31 Mei 2026 | N-PORT |
| CLSE · Trust for Professional Managers | 0,49% | 40.488 NS | 31 Mei 2026 | N-PORT |
| PSC · Principal Exchange-Traded Funds | 0,47% | 135.289 NS | 30 Juni 2026 | N-PORT |
| HQGO · Lattice Strategies Trust | 0,43% | 3.203 NS | 30 April 2026 | N-PORT |
| OASC · Unified Series Trust | 0,40% | 4.569 NS | 31 Mei 2026 | N-PORT |
| BRNY · EA Series Trust | 0,40% | 34.057 NS | 30 April 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,34% | 35.034 NS | 31 Mei 2026 | N-PORT |
| ESSC · Strategy Shares | 0,34% | 1.335 NS | 30 April 2026 | N-PORT |
| BIB · ProShares Trust | 0,31% | 3.062 NS | 31 Mei 2026 | N-PORT |
| FSCC · Federated Hermes ETF Trust | 0,31% | 11.451 NS | 31 Mei 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,30% | 39.411 NS | 31 Mei 2026 | N-PORT |
| SAA · ProShares Trust | 0,26% | 961 NS | 31 Mei 2026 | N-PORT |
| ROUS · Lattice Strategies Trust | 0,25% | 22.443 NS | 30 April 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,24% | 27.276 NS | 30 April 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,23% | 2.877 NS | 30 April 2026 | N-PORT |
| AFSM · First Trust Exchange-Traded Fund VI… | 0,23% | 3.003 NS | 31 Mei 2026 | N-PORT |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,20% | 39.967 NS | 30 April 2026 | N-PORT |
| RSSL · Global X Funds | 0,16% | 34.125 NS | 30 April 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,15% | 11.071 NS | 30 April 2026 | N-PORT |
| ITWO · ProShares Trust | 0,15% | 3.710 NS | 31 Mei 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0,14% | 49.932 NS | 30 April 2026 | N-PORT |
| SMDX · Tidal Trust III | 0,13% | 2.579 NS | 30 April 2026 | N-PORT |
| SXQG · EXCHANGE TRADED CONCEPTS TRUST | 0,13% | 1.182 NS | 31 Mei 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,13% | 386.068 NS | 31 Mei 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,09% | 190.421 NS | 30 April 2026 | N-PORT |
| UWM · ProShares Trust | 0,09% | 2.899 NS | 31 Mei 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,08% | 33.415 NS | 30 April 2026 | N-PORT |
| FYEE · Fidelity Greenwood Street Trust | 0,07% | 1.913 NS | 30 April 2026 | N-PORT |
| URTY · ProShares Trust | 0,06% | 2.936 NS | 31 Mei 2026 | N-PORT |
| FBUF · Fidelity Greenwood Street Trust | 0,05% | 154 NS | 30 April 2026 | N-PORT |
| AFMC · First Trust Exchange-Traded Fund VI… | 0,05% | 1.112 NS | 31 Mei 2026 | N-PORT |
| TILT · FlexShares Trust | 0,04% | 13.552 NS | 30 April 2026 | N-PORT |
| HDG · ProShares Trust | 0,03% | 74 NS | 31 Mei 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,02% | 6.829 NS | 30 April 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,01% | 95.919 NS | 30 April 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,01% | 17.796 NS | 31 Mei 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,01% | 47.658 NS | 31 Mei 2026 | N-PORT |
| AVSU · AMERICAN CENTURY ETF TRUST | 0,01% | 506 NS | 31 Mei 2026 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0,01% | 273 NS | 31 Mei 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,01% | 21.258 NS | 30 April 2026 | N-PORT |
| FHEQ · Fidelity Greenwood Street Trust | 0,01% | 861 NS | 30 April 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 7.872 NS | 30 April 2026 | N-PORT |
| FTLS · First Trust Exchange-Traded Fund III | -0,10% | -33.590 NS | 30 April 2026 | N-PORT |